Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
The @doximity Residency Navigator ranked 24 @UMich residency programs among the top 25 in the nation. A big shoutout to our outstanding residency programs and the teams behind them! https://t.co/muBJ7NIQpJ
Predicting cure and hypocalcemia by intraoperative parathyroid hormone decline in normohormonal primary hyperparathyroidism: A multi-institutional validation study https://t.co/9SHGIWezRJ Great @SurgJournal study by @KravchenkoTim@UMichSurgery@TheAAES@pennsurgery
Excited about our new work on lymph node mapping ultrasound for thyroid cancer in @JSurgRes!
More predictive ultrasound ➡️ higher yield FNA ➡️ lower costs and fewer unnecessary operations
https://t.co/3iot8mm9Lh
@BeninatoToni@amlaird
Today is National #DoctorsDay, a chance to recognize the thousands of physicians, residents and fellows who help Michigan Medicine advance health every day.
THANK YOU, doctors, for all you do at Michigan Medicine. Hail! #NationalDoctorsDay
📷: Illustration by Justine Ross.